These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30852635

  • 1. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY, Liu HY, Chu HS, Chen WL, Hu FR, Wang IJ.
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S, Agrawal D.
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [Abstract] [Full Text] [Related]

  • 3. Tear Tacrolimus Levels and Clinical Response After Adjunct Therapy With Cutaneous Application of Tacrolimus 0.1% Over Upper Eyelid Skin in Chronic Vernal Keratoconjunctivitis.
    Bardoloi P, Vanathi M, Velpandian T, Laxmi M, Gupta N, Lomi N, Tandon R.
    Cornea; 2024 Jul 01; 43(7):820-827. PubMed ID: 37921523
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM, Mirza AG, Al-Hakami AM.
    Middle East Afr J Ophthalmol; 2016 Jul 01; 23(1):135-8. PubMed ID: 26957853
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY.
    Korean J Ophthalmol; 2012 Aug 01; 26(4):241-7. PubMed ID: 22870021
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM.
    Am J Ophthalmol; 2014 Feb 01; 157(2):280-6. PubMed ID: 24439439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q, Tang J, Han Y, Wang D, Ye H.
    Ophthalmic Res; 2018 Feb 01; 59(3):126-134. PubMed ID: 28803239
    [Abstract] [Full Text] [Related]

  • 9. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y, Sakarya R.
    J Ocul Pharmacol Ther; 2012 Feb 01; 28(1):94-6. PubMed ID: 22103968
    [Abstract] [Full Text] [Related]

  • 10. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ.
    Eye (Lond); 2011 Jul 01; 25(7):872-80. PubMed ID: 21475312
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D, Tominaga T, Kakimaru-Hasegawa A, Nagata Y, Hasegawa J, Inoue Y.
    Ophthalmology; 2008 Jun 01; 115(6):988-992.e5. PubMed ID: 17900694
    [Abstract] [Full Text] [Related]

  • 12. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
    García DP, Alperte JI, Cristóbal JA, Mateo Orobia AJ, Muro EM, Valyi Z, Del Rio BJ, Arnao MR.
    Cornea; 2011 Apr 01; 30(4):462-5. PubMed ID: 20861732
    [Abstract] [Full Text] [Related]

  • 13. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P.
    Asian Pac J Allergy Immunol; 2012 Sep 01; 30(3):177-84. PubMed ID: 23156846
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus.
    Hirota A, Shoji J, Inada N, Shiraki Y, Yamagami S.
    Cornea; 2022 Jan 01; 41(1):23-30. PubMed ID: 34870621
    [Abstract] [Full Text] [Related]

  • 15. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA, Soliman TT, Abousaif WS, Shebl AA.
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan 01; 260(1):353-361. PubMed ID: 34453603
    [Abstract] [Full Text] [Related]

  • 16. Application for tacrolimus ointment in treating refractory inflammatory ocular surface diseases.
    Lee YJ, Kim SW, Seo KY.
    Am J Ophthalmol; 2013 May 01; 155(5):804-13. PubMed ID: 23394907
    [Abstract] [Full Text] [Related]

  • 17. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA, Kaufman HE, Insler M.
    Cornea; 2005 May 01; 24(4):417-20. PubMed ID: 15829797
    [Abstract] [Full Text] [Related]

  • 18. Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
    Müller GG, José NK, de Castro RS, de Holanda EC.
    Arq Bras Oftalmol; 2019 May 01; 82(2):119-123. PubMed ID: 30698232
    [Abstract] [Full Text] [Related]

  • 19. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK, Pawar N, Ravindran M, Allapitchai F, Rengappa R.
    J AAPOS; 2019 Feb 01; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [Abstract] [Full Text] [Related]

  • 20. When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol.
    Arnon R, Rozen-Knisbacher I, Yahalomi T, Stanescu N, Niazov Y, Goldberg D, Sharabi-Nov A, Mostovoy D.
    Int Ophthalmol; 2022 Jun 01; 42(6):1771-1780. PubMed ID: 34981294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.